Publications by authors named "Chris Webber"

Claim this Profile
C
CLOVER (CLOstridium difficile Vaccine Efficacy tRial) Study: A Phase 3, Randomized Trial Investigating the Efficacy and Safety of a Detoxified Toxin A/B Vaccine in Adults 50 Years and Older at Increased Risk of Clostridioides difficile Infection.
Curtis J Donskey, Erik R Dubberke, Nicola P Klein, Elizabeth G Liles, Katarzyna Szymkowiak, Chris Webber

Clin Infect Dis· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AZD3152 neutralizes SARS-CoV-2 historical and contemporary variants and is protective in hamsters and well tolerated in adults.
Yingyun Cai, Seme Diallo, Kim Rosenthal, Kuishu Ren, Daniel J Flores, Chris Webber

Sci Transl Med· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Accelerating therapeutics development during a pandemic: population pharmacokinetics of the long-acting antibody combination AZD7442 (tixagevimab/cilgavimab) in the prophylaxis and treatment of COVID-19.
Lindsay E Clegg, Oleg Stepanov, Henning Schmidt, Weifeng Tang, Huixia Zhang, Chris Webber

Antimicrob Agents Chemother· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase 2 Extension Study Evaluating the Immunogenicity, Safety, and Tolerability of 3 or 4 Doses of a Clostridioides difficile Vaccine in Healthy US Adults Aged 65 to 85 Years.
Shon Remich, Nicholas Kitchin, James Peterson, Ping Li, Michael W Pride, Chris Webber

J Infect Dis· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 3 study evaluating the lot consistency, immunogenicity, safety, and tolerability of a Clostridioides difficile vaccine in healthy adults 65 to 85 years of age.
Shane Christensen, Salim Bouguermouh, Kumar Ilangovan, Michael W Pride, Chris Webber

Vaccine· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of BNT162b2 Covid-19 Vaccine in Children Younger than 5 Years of Age.
Flor M Muñoz, Lawrence D Sher, Charu Sabharwal, Alejandra Gurtman, Xia Xu, Chris Webber

N Engl J Med· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 3, randomized, controlled, open-label study to evaluate the persistence up to 5 years of 1 or 2 doses of meningococcal conjugate vaccine MenACWY-TT given with or without 13-valent pneumococcal conjugate vaccine in 12-14-month-old children.
Clare L Cutland, Paula Peyrani, Chris Webber, Ryan Newton, Mark Cutler

Vaccine· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical trial and postmarketing safety experience with MenACWY-TT, a meningococcal group A, C, W, and Y tetanus conjugate vaccine.
Lidia Serra, Chris Webber, Cindy Burman, Patrizia Bueti, Maria Gorruso

Vaccine· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of different Clostridioides (Clostridium) difficile vaccine formulations in two early phase randomized studies of healthy adults aged 50-85 years.
Jody Lawrence, Nicholas Kitchin, Annaliesa S Anderson, Michael W Pride, Kathrin U Jansen, Chris Webber

Vaccine· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Persistence of bactericidal antibodies following primary and booster MenACWY-TT vaccination of toddlers: A review of clinical studies.
Chris Webber, Paula Peyrani, Paul Balmer, Lidia Serra

Vaccine· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of a booster dose of the meningococcal A, C, W, Y-tetanus toxoid conjugate vaccine administered 10 years after primary vaccination and long-term persistence of tetanus toxoid conjugate or polysaccharide vaccine.
Beatriz Quiambao, Paula Peyrani, Ping Li, Mark W Cutler, Marie Van Der Wielen, Chris Webber

Hum Vaccin Immunother· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 2b/3b MenACWY-TT study of long-term antibody persistence after primary vaccination and immunogenicity and safety of a booster dose in individuals aged 11 through 55 years.
Charissa Fay Corazon Borja-Tabora, Paula Peyrani, Chris Webber, Marie Van der Wielen, Brigitte Cheuvart

BMC Infect Dis· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Ten-Year Antibody Persistence and Booster Response to MenACWY-TT Vaccine After Primary Vaccination at 1-10 Years of Age.
Timo Vesikari, Paula Peyrani, Chris Webber, Marie Van Der Wielen, Brigitte Cheuvart

Hum Vaccin Immunother· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term antibody persistence after a booster dose of quadrivalent meningococcal ACWY-tetanus toxoid conjugate vaccine in healthy 5-year-old children.
Timo Vesikari, Aino Forsten, France Laudat, Ping Li, Marie Van Der Wielen, Chris Webber

Vaccine· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase 2 Study Evaluating the Safety, Tolerability, and Immunogenicity of Two 3-Dose Regimens of a Clostridium difficile Vaccine in Healthy US Adults Aged 65 to 85 Years.
Nicholas Kitchin, Shon A Remich, James Peterson, Yahong Peng, William C Gruber, Chris Webber

Clin Infect Dis· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A public health evaluation of 13-valent pneumococcal conjugate vaccine impact on adult disease outcomes from a randomized clinical trial in the Netherlands.
Bradford D Gessner, Qin Jiang, Cornelis H Van Werkhoven, Heather L Sings, Chris Webber

Vaccine· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A post-hoc analysis of serotype-specific vaccine efficacy of 13-valent pneumococcal conjugate vaccine against clinical community acquired pneumonia from a randomized clinical trial in the Netherlands.
Bradford D Gessner, Qin Jiang, Cornelis H Van Werkhoven, Heather L Sings, Chris Webber

Vaccine· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 1 randomized study assessing safety and immunogenicity of two 3-dose regimens of a Clostridium difficile vaccine in healthy older Japanese adults.
Megumi Inoue, Takuma Yonemura, Richard de Solom, Masako Yamaji, Masakazu Aizawa, Chris Webber

Vaccine· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Late onset of injection site reactions after vaccination with the 13-valent pneumococcal conjugate vaccine in adult study populations.
Christine Juergens, James Trammel, Yasuko Shoji, Scott Patterson, Wendy Watson, Chris Webber

Hum Vaccin Immunother· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
'
'Perhaps a Bit Different to What We Did Twenty Years Ago': Senior Teachers' Perceptions of Outdoor Adventure within Primary Education in England.
Chris Webber, Ashley Hardwell

Sports (Basel)· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Meningococcal Group A, C, W, and Y Tetanus Toxoid Conjugate Vaccine: A Review of Clinical Data in Adolescents.
Lidia C Serra, Laura J York, Paul Balmer, Chris Webber

J Adolesc Health· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Impact of the 13-Valent Pneumococcal Conjugate Vaccine on Pneumococcal Carriage in the Community Acquired Pneumonia Immunization Trial in Adults (CAPiTA) Study.
Anna M M van Deursen, Marlies A van Houten, Chris Webber, Michael Patton, Daniel Scott

Clin Infect Dis· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Review of Meningococcal Disease and Vaccination Recommendations for Travelers.
Lidia C Serra, Laura J York, Amgad Gamil, Paul Balmer, Chris Webber

Infect Dis Ther· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Post hoc analysis of the efficacy of the 13-valent pneumococcal conjugate vaccine against vaccine-type community-acquired pneumonia in at-risk older adults.
José A Suaya, Qin Jiang, Daniel A Scott, William C Gruber, Chris Webber

Vaccine· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploratory efficacy endpoints in the Community-Acquired Pneumonia Immunization Trial in Adults (CAPiTA).
Chris Webber, Michael Patton, Marc J M Bonten,

Vaccine· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis